Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma

Citation Download

Ugurel M, Schadendorf D, Fink W, Zimpfer-Rechner C, Thoelke A, Figl R, Kaatz M:
Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma.
Onkologie 2004;27:540-544 (DOI: 10.1159/000081335)

Download:

As text file

Using Citation Manager Software
(EndNote / Reference Manager / ProCite)

Purchase Citation Manager Software:

EndNote

Back

Search in this issue

This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.